226 related articles for article (PubMed ID: 20215415)
1. Expression profiling after activation of amino acid deprivation response in HepG2 human hepatoma cells.
Shan J; Lopez MC; Baker HV; Kilberg MS
Physiol Genomics; 2010 May; 41(3):315-27. PubMed ID: 20215415
[TBL] [Abstract][Full Text] [Related]
2. MAPK signaling triggers transcriptional induction of cFOS during amino acid limitation of HepG2 cells.
Shan J; Donelan W; Hayner JN; Zhang F; Dudenhausen EE; Kilberg MS
Biochim Biophys Acta; 2015 Mar; 1853(3):539-48. PubMed ID: 25523140
[TBL] [Abstract][Full Text] [Related]
3. Auto-activation of c-JUN gene by amino acid deprivation of hepatocellular carcinoma cells reveals a novel c-JUN-mediated signaling pathway.
Fu L; Balasubramanian M; Shan J; Dudenhausen EE; Kilberg MS
J Biol Chem; 2011 Oct; 286(42):36724-38. PubMed ID: 21862593
[TBL] [Abstract][Full Text] [Related]
4. The RNA expression signature of the HepG2 cell line as determined by the integrated analysis of miRNA and mRNA expression profiles.
Bai Y; Xue Y; Xie X; Yu T; Zhu Y; Ge Q; Lu Z
Gene; 2014 Sep; 548(1):91-100. PubMed ID: 25014136
[TBL] [Abstract][Full Text] [Related]
5. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
6. Gene expression and pathway analysis of human hepatocellular carcinoma cells treated with cadmium.
Cartularo L; Laulicht F; Sun H; Kluz T; Freedman JH; Costa M
Toxicol Appl Pharmacol; 2015 Nov; 288(3):399-408. PubMed ID: 26314618
[TBL] [Abstract][Full Text] [Related]
7. Induction of p21 and p27 expression by amino acid deprivation of HepG2 human hepatoma cells involves mRNA stabilization.
Leung-Pineda V; Pan Y; Chen H; Kilberg MS
Biochem J; 2004 Apr; 379(Pt 1):79-88. PubMed ID: 14715082
[TBL] [Abstract][Full Text] [Related]
8. Gene network analysis leads to functional validation of pathways linked to cancer cell growth and survival.
Berger E; Vega N; Vidal H; Geloën A
Biotechnol J; 2012 Nov; 7(11):1395-404. PubMed ID: 22930530
[TBL] [Abstract][Full Text] [Related]
9. HepG2/C3A cells respond to cysteine deprivation by induction of the amino acid deprivation/integrated stress response pathway.
Lee JI; Dominy JE; Sikalidis AK; Hirschberger LL; Wang W; Stipanuk MH
Physiol Genomics; 2008 Apr; 33(2):218-29. PubMed ID: 18285520
[TBL] [Abstract][Full Text] [Related]
10. Gene expression signature of human HepG2 cell line.
Costantini S; Di Bernardo G; Cammarota M; Castello G; Colonna G
Gene; 2013 Apr; 518(2):335-45. PubMed ID: 23357223
[TBL] [Abstract][Full Text] [Related]
11. The HOX gene network in hepatocellular carcinoma.
Cillo C; Schiavo G; Cantile M; Bihl MP; Sorrentino P; Carafa V; D' Armiento M; Roncalli M; Sansano S; Vecchione R; Tornillo L; Mori L; De Libero G; Zucman-Rossi J; Terracciano L
Int J Cancer; 2011 Dec; 129(11):2577-87. PubMed ID: 21626505
[TBL] [Abstract][Full Text] [Related]
12. Silencing of DNA-PKcs alters the transcriptional profile of certain signal transduction genes related to proliferation and differentiation in HeLa cells.
An J; Xu QZ; Sui JL; Bai B; Zhou PK
Int J Mol Med; 2005 Sep; 16(3):455-62. PubMed ID: 16077955
[TBL] [Abstract][Full Text] [Related]
13. Amino-acid limitation induces transcription from the human C/EBPbeta gene via an enhancer activity located downstream of the protein coding sequence.
Chen C; Dudenhausen E; Chen H; Pan YX; Gjymishka A; Kilberg MS
Biochem J; 2005 Nov; 391(Pt 3):649-58. PubMed ID: 16026328
[TBL] [Abstract][Full Text] [Related]
14. Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.
Wang Z; Wei W; Sun CK; Chua MS; So S
Liver Int; 2015 Apr; 35(4):1403-15. PubMed ID: 25098386
[TBL] [Abstract][Full Text] [Related]
15. Identification of palmitate-regulated genes in HepG2 cells by applying microarray analysis.
Vock C; Gleissner M; Klapper M; Döring F
Biochim Biophys Acta; 2007 Sep; 1770(9):1283-8. PubMed ID: 17658692
[TBL] [Abstract][Full Text] [Related]
16. Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma.
Xu L; Hui L; Wang S; Gong J; Jin Y; Wang Y; Ji Y; Wu X; Han Z; Hu G
Cancer Res; 2001 Apr; 61(7):3176-81. PubMed ID: 11306505
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of E2F3b in human HepG2 liver cancer cell line.
Lu Y; Li W
J Cell Biochem; 2018 Apr; 119(4):3429-3439. PubMed ID: 29135049
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion.
Li Q; Wang G; Shan JL; Yang ZX; Wang HZ; Feng J; Zhen JJ; Chen C; Zhang ZM; Xu W; Luo XZ; Wang D
J Gastroenterol Hepatol; 2010 Jan; 25(1):164-71. PubMed ID: 19793168
[TBL] [Abstract][Full Text] [Related]
19. Emodin inhibits the growth of hepatoma cells: finding the common anti-cancer pathway using Huh7, Hep3B, and HepG2 cells.
Hsu CM; Hsu YA; Tsai Y; Shieh FK; Huang SH; Wan L; Tsai FJ
Biochem Biophys Res Commun; 2010 Feb; 392(4):473-8. PubMed ID: 19895793
[TBL] [Abstract][Full Text] [Related]
20. Identification of MicroRNAs and target genes involvement in hepatocellular carcinoma with microarray data.
Wang D; Tan J; Xu Y; Tan X; Han M; Tu Y; Zhu Z; Zen J; Dou C; Cai S
Hepatogastroenterology; 2015; 62(138):378-82. PubMed ID: 25916067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
